Inventor · Boulder, CO, US

Michael Lyon

13Patents
6h-index
46Co-inventors
62Inventor score

Filing activity: Jul 21, 2006 → Aug 23, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US8299021B2 Macrocyclic inhibitors of hepatitis C virus replication Emerging Cross-Sectional Technologies 45 Active
US7829665B2 Macrocyclic inhibitors of hepatitis C virus replication Emerging Cross-Sectional Technologies 19 Active
US8178131B2 Pyrrolopyridines as kinase inhibitors Chemistry; Metallurgy 18 Active
US8545897B2 Pyrrolopyridines as kinase inhibitors Chemistry; Metallurgy 8 Active
US8981085B2 Pyrrolopyridines as kinase inhibitors Chemistry; Metallurgy 6 Active
US8758830B2 Pyrrolopyridines as kinase inhibitors Chemistry; Metallurgy 6 Active
US9763942B2 Serine/threonine kinase inhibitors Chemistry; Metallurgy 5 Active
US9969727B2 Pyrrolopyridines as kinase inhibitors Chemistry; Metallurgy 4 Active
US10154995B2 Serine/threonine kinase inhibitors Chemistry; Metallurgy 3 Active
US9365568B2 Pyrrolopyridines as kinase inhibitors Chemistry; Metallurgy 3 Active
US9670208B2 Serine/threonine kinase inhibitors Chemistry; Metallurgy 3 Active
US8889704B2 Triazolopyridine compounds as PIM kinase inhibitors Chemistry; Metallurgy 0 Active
US7932277B2 Peptide inhibitors of hepatitis C virus replication Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.